MUTHU RAJA, Karthick Raja, Lenka ZAHRADOVÁ, Zuzana MIKULKOVÁ, Marek CIBULKA, Ivana BUREŠOVÁ, Lucie KOVÁŘOVÁ, Roman HÁJEK and Jaroslav MICHÁLEK. A preliminary study report of T regulatory cells in pre and post treated myeloma patients. In 15th Congress of the European Hematology Association. 2010. ISSN 0390-6078.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name A preliminary study report of T regulatory cells in pre and post treated myeloma patients
Name in Czech T regulačná lymfocyty u pacientů s mnohočetným myelomem před a po léčbě
Authors MUTHU RAJA, Karthick Raja, Lenka ZAHRADOVÁ, Zuzana MIKULKOVÁ, Marek CIBULKA, Ivana BUREŠOVÁ, Lucie KOVÁŘOVÁ, Roman HÁJEK and Jaroslav MICHÁLEK.
Edition 15th Congress of the European Hematology Association, 2010.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30200 3.2 Clinical medicine
Country of publisher Spain
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 6.532
Organization unit Faculty of Medicine
ISSN 0390-6078
UT WoS 000279051302062
Keywords (in Czech) Treg lymfocyty; mnohočetný myelom
Keywords in English Multiple myeloma, T regulatory cells, Transplant, Treatment
Changed by Changed by: Mgr. Anna Potáčová, Ph.D., učo 44190. Changed: 4/8/2010 13:40.
Abstract
As anticipated, CD4+ Treg cells were found to be increased more prominently in MM pts. From this preliminary study report no strong conclusion can be drawn but a paradigm of reduction in Treg cells was documented in post treated and transplanted pts. Therefore, the impact of Treg cells in pre and post treated MM pts must be acknowledged in large series of pts.
Links
GAP304/10/1395, research and development projectName: Analýza klonálních progenitorů plazmatických buněk u monoklonálních gamapatií
Investor: Czech Science Foundation
LC06027, research and development projectName: Univerzitní výzkumné centrum - Česká myelomová skupina (Acronym: LC MGUS)
Investor: Ministry of Education, Youth and Sports of the CR, University Research Centre - Czech Myeloma Group
MSM0021622434, plan (intention)Name: Od klasických prognostických markerů ke klinicky aplikovatelným farmakogenomickým a farmakoproteomickým projektům u mnohočetného myelomu a monoklonálních gamapatií
Investor: Ministry of Education, Youth and Sports of the CR, From classic prognostic markers to clinical applications in selected pharmacogenomic and pharmacoproteomic projects in multiple myeloma and monoclonal gammapathies
2B08066, research and development projectName: Studium léčebných možností diabetes mellitus 1. typu jako geneticky determinované metabolické choroby s využitím nových imunoterapeutických postupů
PrintDisplayed: 27/9/2024 14:16